SlideShare a Scribd company logo
Running head: VACCINATION FOR HUMAN PAPILLOMAVIRUS (HPV) IN U.S 1
Pub Hlth Policy & Advocacy_Dr. Obumneke_Amadi-Onuoha_Transcript 33
Vaccination for Human Papillomavirus (HPV) In U.S
Table of Contents
Title page…………………………………………………………………………..1
Table of Contents………………………………………………………………….2
Introduction..............................................................................................................3
Statement of the Problem.........................................................................................3
Background………………………………………………………………………..3
Government laws and policies overview………………………………………….4
Parental rights……………………………………………………………..4
Vaccinations requirements and recommendations………………………..4
Intervention(s)…………………………………………………………………..4-5
Conclusion………………………………………………………………………...5
References………………………………………………………………………...6
VACCINATION FOR HUMAN PAPILLOMAVIRUS 2
Introduction
Human papillomaviruses (HPV) are common viruses that puts people at risk for cancer,
they also HPV are contacted through sexual contact with an infected partner. There are 100
different types of HPV cancer some are high risk, and some are low risk (MedlinePlus, 2014).
Low-risk HPV can cause genital warts, whereas, high-risk HPV can lead to cervical, vulva,
vaginal, and anal cancers in women and men, it can lead to anal and genital cancers.
The symptoms of HPV are different on an individual basis, such that some people can
develop warts from the infection while others don’t develop any symptom. The symptom is
treatable through an appropriate procedure by the health care specialist. The screening for HPV
is conducted through a test in women, to identify deviations in the cervix that might lead to
cervical cancer known as Pap tests or HPV tests. (MedlinePlus, 2014).
Problem Statement
Are their parental and population rights to receive a vaccination against HPV infection
from public health authority and how informed are they about the disease manifestation.
Background
About 79 million Americans are currently infected with HPV, and about 14 million
people become newly infected each year (CDC, 2014). It is a fact that the infection with definite
types of HPV is the causative agents of cervical cancer in women and others in men that has led
to new research on its prevention. Primary prevention of cervical cancer can be realized through
prevention and control of genital infection from an infected person. Educating the public
through awareness programs on sexually transmitted infections of public health importance are
other measures of prevention that can effective in preventing HPV infection. Approximately
research on the security and effectiveness of the vaccines against HPV have “shown very
VACCINATION FOR HUMAN PAPILLOMAVIRUS 3
promising results with nearly 100% efficacy” (Franco and Harper, 2005) in the prevention of the
risk factors, development of firm infections and precancerous lesions. However, further
experimental studies are being examined to provide additional indication of HPV vaccine
effectiveness and will form the basis for certifying of the vaccines by the major therapeutic
corporations (Franco and Harper, 2005).
HPV Governmental Policy
The Food and Drug Administration licensed a vaccine against human papillomavirus
(HPV) on September 12, 2006. group of lawmakers from Michigan State became the first in the
United States to recommend that vaccination be made enforced for girls entering sixth grade.
However, they explained that parents who object to the recommendation can opt out of the
requirement as applicable to other vaccination laws (Colgrove, 2006. Para.1).
The government does not have the right to override parental rights in relation to HPV
vaccination, from the perspective of informed consent which is guided by the law, even though,
consents is not a requirement in the federal rules before vaccination, however, “the National
Childhood Vaccine Injury Act of 1986 requires that doctors give vaccine recipients, or their
parents or legal representatives, a Vaccine Information Statement (VIS)” which provides basic
information about vaccine risks and profits to assist parent or patients to make an informed
decision towards receiving vaccinations against HPV (The College of Physicians of
Philadelphia,2014, para.12).
Diseases and illnesses are meant to be treated when we develop them, basically it looks
unethical to cure something that is not developed yet, but, if there is a necessity for prevention
because of possible exposure then treatment can be applied to stay safe, therefore vaccinations
should remain a recommendation for use at the appropriate time.
VACCINATION FOR HUMAN PAPILLOMAVIRUS 4
Intervention(S)
An intervention currently in place to address HPV issue is a 13 minute DVD video titled
“1-2-3 Pap a product developed by a group of researchers from University of Kentucky PRC,
series encourages women to complete the 3-dose human papillomavirus (HPV) vaccine series.
As a primary approach to preventing cervical cancer and it can be concluded within six months.
It can be viewed on a laptop using a headphone, however women who watched the DVD were
more likely to complete the series than the women who received standard care. The product has
the capability to reach and be adapted in underserved areas with high rates of cervical cancer
(CDC, 2013, p.2).
I would propose an alternative intervention to address HPV infection within the
population by developing a social media web-based questionnaire that generates personalized
reports for the prevention and treatments that give recommendations on vaccination options to
improve practices.
Conclusion
HPV infection is a notable and prevalent diseases in the U.S and globally. The
government and the public health professional are working together to provide a realizable
prevention and treatment to the entire population through vaccination, however, they would also
need the support of the people in other to realize their goal of optimal level.
VACCINATION FOR HUMAN PAPILLOMAVIRUS 5
References
CDC (2014). Human Papillomavirus (HPV). Genital HPV infection - fact sheet. Retrieved from
http://www.cdc.gov/std/hpv/stdfact-hpv.htm
Colgrove, J. (2006). The ethics and politics of compulsory HPV vaccination. New England
Journal of Medicine, 355(23), 2389-2391.
CDC (2013).Selected Contributions to Public Health: Workplace and Clinical Interventions.
Retrieved from http://www.cdc.gov/prc/about-prc-program/contributions/workplace.htm
Franco, E. L., & Harper, D. M. (2005). Vaccination against human papillomavirus infection: a
new paradigm in cervical cancer control. Vaccine, 23(17), 2388-2394.
MedlinePlus (2014).HPV. Retrieved from http://www.nlm.nih.gov/medlineplus/hpv.html
The College of Physicians of Philadelphia (2014).Ethical Issues and Vaccines. Retrieved from
http://www.historyofvaccines.org/content/articles/ethical-issues-and-vaccines

More Related Content

What's hot

CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and VaccinationCONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
MichaelFKF
 
Hot Topic: Table B — dengue-con_pak recomendations
Hot Topic: Table B — dengue-con_pak recomendationsHot Topic: Table B — dengue-con_pak recomendations
Hot Topic: Table B — dengue-con_pak recomendationsSkoll Global Threats Fund
 
2015 Family Planning Preconference Jim Shelton
2015 Family Planning Preconference Jim Shelton2015 Family Planning Preconference Jim Shelton
2015 Family Planning Preconference Jim Shelton
Christian Connections for International Health
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
Warren Kibbe
 
Role of data in precision oncology
Role of data in precision oncologyRole of data in precision oncology
Role of data in precision oncology
Warren Kibbe
 
Frew Owens Saint-Victor et al 2014
Frew Owens Saint-Victor et al 2014Frew Owens Saint-Victor et al 2014
Frew Owens Saint-Victor et al 2014Lauren Owens, MPH
 
Towards Digital Pathogen Surveillance
Towards Digital Pathogen SurveillanceTowards Digital Pathogen Surveillance
Towards Digital Pathogen Surveillance
Jennifer Gardy
 
Hawaii - Return to New Normal - Keeping People and Communities Safe
Hawaii - Return to New Normal - Keeping People and Communities SafeHawaii - Return to New Normal - Keeping People and Communities Safe
Hawaii - Return to New Normal - Keeping People and Communities Safe
Clifton M. Hasegawa & Associates, LLC
 
Childhood Vaccinations: Questions All Parents Should Ask
Childhood Vaccinations: Questions All Parents Should AskChildhood Vaccinations: Questions All Parents Should Ask
Childhood Vaccinations: Questions All Parents Should Askstellablue
 
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!Baltic PR Awards
 
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Root India Healthcare
 

What's hot (15)

CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and VaccinationCONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
CONTEMPORARY CLINICAL QUESTIONS on HPV-Related Diseases and Vaccination
 
Hot Topic: Table B — dengue-con_pak recomendations
Hot Topic: Table B — dengue-con_pak recomendationsHot Topic: Table B — dengue-con_pak recomendations
Hot Topic: Table B — dengue-con_pak recomendations
 
Vaccine talk
Vaccine talkVaccine talk
Vaccine talk
 
2015 Family Planning Preconference Jim Shelton
2015 Family Planning Preconference Jim Shelton2015 Family Planning Preconference Jim Shelton
2015 Family Planning Preconference Jim Shelton
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
 
Role of data in precision oncology
Role of data in precision oncologyRole of data in precision oncology
Role of data in precision oncology
 
Frew Owens Saint-Victor et al 2014
Frew Owens Saint-Victor et al 2014Frew Owens Saint-Victor et al 2014
Frew Owens Saint-Victor et al 2014
 
Towards Digital Pathogen Surveillance
Towards Digital Pathogen SurveillanceTowards Digital Pathogen Surveillance
Towards Digital Pathogen Surveillance
 
Group 5
Group 5Group 5
Group 5
 
Hawaii - Return to New Normal - Keeping People and Communities Safe
Hawaii - Return to New Normal - Keeping People and Communities SafeHawaii - Return to New Normal - Keeping People and Communities Safe
Hawaii - Return to New Normal - Keeping People and Communities Safe
 
Childhood Vaccinations: Questions All Parents Should Ask
Childhood Vaccinations: Questions All Parents Should AskChildhood Vaccinations: Questions All Parents Should Ask
Childhood Vaccinations: Questions All Parents Should Ask
 
Lin Final Version - Final
Lin Final Version - FinalLin Final Version - Final
Lin Final Version - Final
 
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!
Corporate sustainability & responsibility 2007 / 1st Place / Izvēlies dzīvot!
 
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
Wondering facts hpv vaccines are reducing infections, warts and probably cancer.
 
Understanding Parents Decisions to Vaccinate Children 3 24 11
Understanding Parents Decisions to Vaccinate Children 3 24 11Understanding Parents Decisions to Vaccinate Children 3 24 11
Understanding Parents Decisions to Vaccinate Children 3 24 11
 

Similar to Dr. Obumneke Amadi-Onuoha_Scripts-33

Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) Vaccine
Keith Wassung
 
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, EdHuman PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
NarcisaBrandenburg70
 
Vacunacion pvh
Vacunacion pvhVacunacion pvh
Vacunacion pvh
rubenhuaraz
 
REVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdfREVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdf
ManuelDiazEstrada2
 
Vaccination Against Cervical Cancer
Vaccination Against Cervical CancerVaccination Against Cervical Cancer
Vaccination Against Cervical CancerRaymond Arhin
 
Vaccine safety
Vaccine safetyVaccine safety
Vaccine safety
pediatricsmgmcri
 
Is flu prevention possible? [Living Well Magazine March/April 2016]
Is flu prevention possible?  [Living Well Magazine March/April 2016]Is flu prevention possible?  [Living Well Magazine March/April 2016]
Is flu prevention possible? [Living Well Magazine March/April 2016]
BiondVax Pharmaceuticals Ltd.
 
Hpv powerpoint bio in the news
Hpv powerpoint bio in the newsHpv powerpoint bio in the news
Hpv powerpoint bio in the news
kgreine
 
Human Papillomavirus Immunization completion rates increased by the use of th...
Human Papillomavirus Immunization completion rates increased by the use of th...Human Papillomavirus Immunization completion rates increased by the use of th...
Human Papillomavirus Immunization completion rates increased by the use of th...
inventionjournals
 
HPV vaccinations
HPV vaccinationsHPV vaccinations
HPV vaccinations
lshie223
 
PA 513 Lisa Lasker Policy and Evaluation Final
PA 513 Lisa Lasker Policy and Evaluation FinalPA 513 Lisa Lasker Policy and Evaluation Final
PA 513 Lisa Lasker Policy and Evaluation FinalLisa Lasker
 
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
The Bixby Center on Population and Reproductive Health
 
Should individual rights (e.g., parents’ right to decide whether to .docx
Should individual rights (e.g., parents’ right to decide whether to .docxShould individual rights (e.g., parents’ right to decide whether to .docx
Should individual rights (e.g., parents’ right to decide whether to .docx
manningchassidy
 
Summer 2006 faq
Summer 2006 faqSummer 2006 faq
Summer 2006 faq
elearning obste
 
Hpv y ca cervical causalidad
Hpv y ca cervical causalidadHpv y ca cervical causalidad
Hpv y ca cervical causalidad
Raul Campusano
 
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdfBIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
bkbk37
 

Similar to Dr. Obumneke Amadi-Onuoha_Scripts-33 (16)

Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) Vaccine
 
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, EdHuman PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
Human PapillomavirusVaccineUSU, FNP 590 Health Promotion, Ed
 
Vacunacion pvh
Vacunacion pvhVacunacion pvh
Vacunacion pvh
 
REVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdfREVISTA VACUNACION VPH Semana 10.pdf
REVISTA VACUNACION VPH Semana 10.pdf
 
Vaccination Against Cervical Cancer
Vaccination Against Cervical CancerVaccination Against Cervical Cancer
Vaccination Against Cervical Cancer
 
Vaccine safety
Vaccine safetyVaccine safety
Vaccine safety
 
Is flu prevention possible? [Living Well Magazine March/April 2016]
Is flu prevention possible?  [Living Well Magazine March/April 2016]Is flu prevention possible?  [Living Well Magazine March/April 2016]
Is flu prevention possible? [Living Well Magazine March/April 2016]
 
Hpv powerpoint bio in the news
Hpv powerpoint bio in the newsHpv powerpoint bio in the news
Hpv powerpoint bio in the news
 
Human Papillomavirus Immunization completion rates increased by the use of th...
Human Papillomavirus Immunization completion rates increased by the use of th...Human Papillomavirus Immunization completion rates increased by the use of th...
Human Papillomavirus Immunization completion rates increased by the use of th...
 
HPV vaccinations
HPV vaccinationsHPV vaccinations
HPV vaccinations
 
PA 513 Lisa Lasker Policy and Evaluation Final
PA 513 Lisa Lasker Policy and Evaluation FinalPA 513 Lisa Lasker Policy and Evaluation Final
PA 513 Lisa Lasker Policy and Evaluation Final
 
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
Understanding HPV vaccine hesitancy from a cultural and social perspective: ...
 
Should individual rights (e.g., parents’ right to decide whether to .docx
Should individual rights (e.g., parents’ right to decide whether to .docxShould individual rights (e.g., parents’ right to decide whether to .docx
Should individual rights (e.g., parents’ right to decide whether to .docx
 
Summer 2006 faq
Summer 2006 faqSummer 2006 faq
Summer 2006 faq
 
Hpv y ca cervical causalidad
Hpv y ca cervical causalidadHpv y ca cervical causalidad
Hpv y ca cervical causalidad
 
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdfBIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
 

More from Discover Health Global Initiative

GlucocorticoidsCorticosteroids_Final Report_Obumneke O.docx
GlucocorticoidsCorticosteroids_Final Report_Obumneke  O.docxGlucocorticoidsCorticosteroids_Final Report_Obumneke  O.docx
GlucocorticoidsCorticosteroids_Final Report_Obumneke O.docx
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail designDr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha -Transcript 36
Dr. Obumneke Amadi-Onuoha -Transcript 36Dr. Obumneke Amadi-Onuoha -Transcript 36
Dr. Obumneke Amadi-Onuoha -Transcript 36
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha -Transcript 35
Dr. Obumneke Amadi-Onuoha -Transcript 35Dr. Obumneke Amadi-Onuoha -Transcript 35
Dr. Obumneke Amadi-Onuoha -Transcript 35
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha -Transcript 34
Dr. Obumneke Amadi-Onuoha -Transcript 34Dr. Obumneke Amadi-Onuoha -Transcript 34
Dr. Obumneke Amadi-Onuoha -Transcript 34
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha -Transcript 33
Dr. Obumneke Amadi-Onuoha -Transcript 33Dr. Obumneke Amadi-Onuoha -Transcript 33
Dr. Obumneke Amadi-Onuoha -Transcript 33
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha _transcript 32
Dr. Obumneke Amadi-Onuoha _transcript 32Dr. Obumneke Amadi-Onuoha _transcript 32
Dr. Obumneke Amadi-Onuoha _transcript 32
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha _transcript 31
Dr. Obumneke Amadi-Onuoha _transcript 31Dr. Obumneke Amadi-Onuoha _transcript 31
Dr. Obumneke Amadi-Onuoha _transcript 31
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha scripts-30
Dr. Obumneke Amadi-Onuoha scripts-30Dr. Obumneke Amadi-Onuoha scripts-30
Dr. Obumneke Amadi-Onuoha scripts-30
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-28
Dr. Obumneke Amadi-Onuoha Scripts-28Dr. Obumneke Amadi-Onuoha Scripts-28
Dr. Obumneke Amadi-Onuoha Scripts-28
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-27
Dr. Obumneke Amadi-Onuoha Scripts-27Dr. Obumneke Amadi-Onuoha Scripts-27
Dr. Obumneke Amadi-Onuoha Scripts-27
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-26
Dr. Obumneke Amadi-Onuoha Scripts-26Dr. Obumneke Amadi-Onuoha Scripts-26
Dr. Obumneke Amadi-Onuoha Scripts-26
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-25
Dr. Obumneke Amadi-Onuoha Scripts-25Dr. Obumneke Amadi-Onuoha Scripts-25
Dr. Obumneke Amadi-Onuoha Scripts-25
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-24
Dr. Obumneke Amadi-Onuoha Scripts-24Dr. Obumneke Amadi-Onuoha Scripts-24
Dr. Obumneke Amadi-Onuoha Scripts-24
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha scripts-23
Dr. Obumneke Amadi-Onuoha scripts-23Dr. Obumneke Amadi-Onuoha scripts-23
Dr. Obumneke Amadi-Onuoha scripts-23
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-22
Dr. Obumneke Amadi-Onuoha Scripts-22Dr. Obumneke Amadi-Onuoha Scripts-22
Dr. Obumneke Amadi-Onuoha Scripts-22
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-21
Dr. Obumneke Amadi-Onuoha Scripts-21Dr. Obumneke Amadi-Onuoha Scripts-21
Dr. Obumneke Amadi-Onuoha Scripts-21
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-20
Dr. Obumneke Amadi-Onuoha Scripts-20Dr. Obumneke Amadi-Onuoha Scripts-20
Dr. Obumneke Amadi-Onuoha Scripts-20
Discover Health Global Initiative
 
Dr. Obumneke Amadi-Onuoha Scripts-19
Dr. Obumneke Amadi-Onuoha Scripts-19Dr. Obumneke Amadi-Onuoha Scripts-19
Dr. Obumneke Amadi-Onuoha Scripts-19
Discover Health Global Initiative
 

More from Discover Health Global Initiative (20)

GlucocorticoidsCorticosteroids_Final Report_Obumneke O.docx
GlucocorticoidsCorticosteroids_Final Report_Obumneke  O.docxGlucocorticoidsCorticosteroids_Final Report_Obumneke  O.docx
GlucocorticoidsCorticosteroids_Final Report_Obumneke O.docx
 
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail designDr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
 
Dr. Obumneke Amadi-Onuoha -Transcript 36
Dr. Obumneke Amadi-Onuoha -Transcript 36Dr. Obumneke Amadi-Onuoha -Transcript 36
Dr. Obumneke Amadi-Onuoha -Transcript 36
 
Dr. Obumneke Amadi-Onuoha -Transcript 35
Dr. Obumneke Amadi-Onuoha -Transcript 35Dr. Obumneke Amadi-Onuoha -Transcript 35
Dr. Obumneke Amadi-Onuoha -Transcript 35
 
Dr. Obumneke Amadi-Onuoha -Transcript 34
Dr. Obumneke Amadi-Onuoha -Transcript 34Dr. Obumneke Amadi-Onuoha -Transcript 34
Dr. Obumneke Amadi-Onuoha -Transcript 34
 
Dr. Obumneke Amadi-Onuoha -Transcript 33
Dr. Obumneke Amadi-Onuoha -Transcript 33Dr. Obumneke Amadi-Onuoha -Transcript 33
Dr. Obumneke Amadi-Onuoha -Transcript 33
 
Dr. Obumneke Amadi-Onuoha _transcript 32
Dr. Obumneke Amadi-Onuoha _transcript 32Dr. Obumneke Amadi-Onuoha _transcript 32
Dr. Obumneke Amadi-Onuoha _transcript 32
 
Dr. Obumneke Amadi-Onuoha _transcript 31
Dr. Obumneke Amadi-Onuoha _transcript 31Dr. Obumneke Amadi-Onuoha _transcript 31
Dr. Obumneke Amadi-Onuoha _transcript 31
 
Dr. Obumneke Amadi-Onuoha scripts-30
Dr. Obumneke Amadi-Onuoha scripts-30Dr. Obumneke Amadi-Onuoha scripts-30
Dr. Obumneke Amadi-Onuoha scripts-30
 
Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29
 
Dr. Obumneke Amadi-Onuoha Scripts-28
Dr. Obumneke Amadi-Onuoha Scripts-28Dr. Obumneke Amadi-Onuoha Scripts-28
Dr. Obumneke Amadi-Onuoha Scripts-28
 
Dr. Obumneke Amadi-Onuoha Scripts-27
Dr. Obumneke Amadi-Onuoha Scripts-27Dr. Obumneke Amadi-Onuoha Scripts-27
Dr. Obumneke Amadi-Onuoha Scripts-27
 
Dr. Obumneke Amadi-Onuoha Scripts-26
Dr. Obumneke Amadi-Onuoha Scripts-26Dr. Obumneke Amadi-Onuoha Scripts-26
Dr. Obumneke Amadi-Onuoha Scripts-26
 
Dr. Obumneke Amadi-Onuoha Scripts-25
Dr. Obumneke Amadi-Onuoha Scripts-25Dr. Obumneke Amadi-Onuoha Scripts-25
Dr. Obumneke Amadi-Onuoha Scripts-25
 
Dr. Obumneke Amadi-Onuoha Scripts-24
Dr. Obumneke Amadi-Onuoha Scripts-24Dr. Obumneke Amadi-Onuoha Scripts-24
Dr. Obumneke Amadi-Onuoha Scripts-24
 
Dr. Obumneke Amadi-Onuoha scripts-23
Dr. Obumneke Amadi-Onuoha scripts-23Dr. Obumneke Amadi-Onuoha scripts-23
Dr. Obumneke Amadi-Onuoha scripts-23
 
Dr. Obumneke Amadi-Onuoha Scripts-22
Dr. Obumneke Amadi-Onuoha Scripts-22Dr. Obumneke Amadi-Onuoha Scripts-22
Dr. Obumneke Amadi-Onuoha Scripts-22
 
Dr. Obumneke Amadi-Onuoha Scripts-21
Dr. Obumneke Amadi-Onuoha Scripts-21Dr. Obumneke Amadi-Onuoha Scripts-21
Dr. Obumneke Amadi-Onuoha Scripts-21
 
Dr. Obumneke Amadi-Onuoha Scripts-20
Dr. Obumneke Amadi-Onuoha Scripts-20Dr. Obumneke Amadi-Onuoha Scripts-20
Dr. Obumneke Amadi-Onuoha Scripts-20
 
Dr. Obumneke Amadi-Onuoha Scripts-19
Dr. Obumneke Amadi-Onuoha Scripts-19Dr. Obumneke Amadi-Onuoha Scripts-19
Dr. Obumneke Amadi-Onuoha Scripts-19
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 

Dr. Obumneke Amadi-Onuoha_Scripts-33

  • 1. Running head: VACCINATION FOR HUMAN PAPILLOMAVIRUS (HPV) IN U.S 1 Pub Hlth Policy & Advocacy_Dr. Obumneke_Amadi-Onuoha_Transcript 33 Vaccination for Human Papillomavirus (HPV) In U.S Table of Contents Title page…………………………………………………………………………..1 Table of Contents………………………………………………………………….2 Introduction..............................................................................................................3 Statement of the Problem.........................................................................................3 Background………………………………………………………………………..3 Government laws and policies overview………………………………………….4 Parental rights……………………………………………………………..4 Vaccinations requirements and recommendations………………………..4 Intervention(s)…………………………………………………………………..4-5 Conclusion………………………………………………………………………...5 References………………………………………………………………………...6
  • 2. VACCINATION FOR HUMAN PAPILLOMAVIRUS 2 Introduction Human papillomaviruses (HPV) are common viruses that puts people at risk for cancer, they also HPV are contacted through sexual contact with an infected partner. There are 100 different types of HPV cancer some are high risk, and some are low risk (MedlinePlus, 2014). Low-risk HPV can cause genital warts, whereas, high-risk HPV can lead to cervical, vulva, vaginal, and anal cancers in women and men, it can lead to anal and genital cancers. The symptoms of HPV are different on an individual basis, such that some people can develop warts from the infection while others don’t develop any symptom. The symptom is treatable through an appropriate procedure by the health care specialist. The screening for HPV is conducted through a test in women, to identify deviations in the cervix that might lead to cervical cancer known as Pap tests or HPV tests. (MedlinePlus, 2014). Problem Statement Are their parental and population rights to receive a vaccination against HPV infection from public health authority and how informed are they about the disease manifestation. Background About 79 million Americans are currently infected with HPV, and about 14 million people become newly infected each year (CDC, 2014). It is a fact that the infection with definite types of HPV is the causative agents of cervical cancer in women and others in men that has led to new research on its prevention. Primary prevention of cervical cancer can be realized through prevention and control of genital infection from an infected person. Educating the public through awareness programs on sexually transmitted infections of public health importance are other measures of prevention that can effective in preventing HPV infection. Approximately research on the security and effectiveness of the vaccines against HPV have “shown very
  • 3. VACCINATION FOR HUMAN PAPILLOMAVIRUS 3 promising results with nearly 100% efficacy” (Franco and Harper, 2005) in the prevention of the risk factors, development of firm infections and precancerous lesions. However, further experimental studies are being examined to provide additional indication of HPV vaccine effectiveness and will form the basis for certifying of the vaccines by the major therapeutic corporations (Franco and Harper, 2005). HPV Governmental Policy The Food and Drug Administration licensed a vaccine against human papillomavirus (HPV) on September 12, 2006. group of lawmakers from Michigan State became the first in the United States to recommend that vaccination be made enforced for girls entering sixth grade. However, they explained that parents who object to the recommendation can opt out of the requirement as applicable to other vaccination laws (Colgrove, 2006. Para.1). The government does not have the right to override parental rights in relation to HPV vaccination, from the perspective of informed consent which is guided by the law, even though, consents is not a requirement in the federal rules before vaccination, however, “the National Childhood Vaccine Injury Act of 1986 requires that doctors give vaccine recipients, or their parents or legal representatives, a Vaccine Information Statement (VIS)” which provides basic information about vaccine risks and profits to assist parent or patients to make an informed decision towards receiving vaccinations against HPV (The College of Physicians of Philadelphia,2014, para.12). Diseases and illnesses are meant to be treated when we develop them, basically it looks unethical to cure something that is not developed yet, but, if there is a necessity for prevention because of possible exposure then treatment can be applied to stay safe, therefore vaccinations should remain a recommendation for use at the appropriate time.
  • 4. VACCINATION FOR HUMAN PAPILLOMAVIRUS 4 Intervention(S) An intervention currently in place to address HPV issue is a 13 minute DVD video titled “1-2-3 Pap a product developed by a group of researchers from University of Kentucky PRC, series encourages women to complete the 3-dose human papillomavirus (HPV) vaccine series. As a primary approach to preventing cervical cancer and it can be concluded within six months. It can be viewed on a laptop using a headphone, however women who watched the DVD were more likely to complete the series than the women who received standard care. The product has the capability to reach and be adapted in underserved areas with high rates of cervical cancer (CDC, 2013, p.2). I would propose an alternative intervention to address HPV infection within the population by developing a social media web-based questionnaire that generates personalized reports for the prevention and treatments that give recommendations on vaccination options to improve practices. Conclusion HPV infection is a notable and prevalent diseases in the U.S and globally. The government and the public health professional are working together to provide a realizable prevention and treatment to the entire population through vaccination, however, they would also need the support of the people in other to realize their goal of optimal level.
  • 5. VACCINATION FOR HUMAN PAPILLOMAVIRUS 5 References CDC (2014). Human Papillomavirus (HPV). Genital HPV infection - fact sheet. Retrieved from http://www.cdc.gov/std/hpv/stdfact-hpv.htm Colgrove, J. (2006). The ethics and politics of compulsory HPV vaccination. New England Journal of Medicine, 355(23), 2389-2391. CDC (2013).Selected Contributions to Public Health: Workplace and Clinical Interventions. Retrieved from http://www.cdc.gov/prc/about-prc-program/contributions/workplace.htm Franco, E. L., & Harper, D. M. (2005). Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine, 23(17), 2388-2394. MedlinePlus (2014).HPV. Retrieved from http://www.nlm.nih.gov/medlineplus/hpv.html The College of Physicians of Philadelphia (2014).Ethical Issues and Vaccines. Retrieved from http://www.historyofvaccines.org/content/articles/ethical-issues-and-vaccines